479 related articles for article (PubMed ID: 26297427)
1. The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option.
Tian J; Wang Y; Guo H; Li R
Exp Mol Pathol; 2015 Dec; 99(3):435-40. PubMed ID: 26297427
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin slows IgA nephropathy progression in the rat.
Tian J; Wang Y; Zhou X; Li Y; Wang C; Li J; Li R
Am J Nephrol; 2014; 39(3):218-29. PubMed ID: 24603476
[TBL] [Abstract][Full Text] [Related]
3. The protective effect and mechanism of rapamycin in the rat model of IgA nephropathy.
Guo N; Liu S; Bow LM; Cui X; Zhang L; Xu S; Lu S; Tian J
Ren Fail; 2019 Nov; 41(1):334-339. PubMed ID: 31057050
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms.
Tian J; Wang Y; Liu X; Zhou X; Li R
Exp Biol Med (Maywood); 2015 Jul; 240(7):936-45. PubMed ID: 25349217
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin Enhances Repressed Autophagy and Attenuates Aggressive Progression in a Rat Model of IgA Nephropathy.
Liu D; Liu Y; Chen G; He L; Tang C; Wang C; Yang D; Li H; Dong Z; Liu H
Am J Nephrol; 2017; 45(4):293-300. PubMed ID: 28237991
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin inhibits the proliferation of IgAN mesangial cells through the mTOR signaling pathway.
Xia M; Liu D; Tang X; Liu Y; Liu H; Liu Y; Chen G; Liu H
Int Immunopharmacol; 2020 Mar; 80():106125. PubMed ID: 31931362
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of the activated mammalian target of rapamycin pathway might be associated with renal function reserve by a low-protein diet in the rat remnant kidney model.
Ohkawa S; Yanagida M; Uchikawa T; Yoshida T; Ikegaya N; Kumagai H
Nutr Res; 2013 Sep; 33(9):761-71. PubMed ID: 24034576
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
[TBL] [Abstract][Full Text] [Related]
9. Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas.
Lin F; Zhang PL; Yang XJ; Prichard JW; Lun M; Brown RE
Ann Clin Lab Sci; 2006; 36(3):283-93. PubMed ID: 16951269
[TBL] [Abstract][Full Text] [Related]
10. PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis.
Faghiri Z; Bazan NG
Exp Eye Res; 2010 Jun; 90(6):718-25. PubMed ID: 20230819
[TBL] [Abstract][Full Text] [Related]
11. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats.
Hu LY; Sun ZG; Wen YM; Cheng GZ; Wang SL; Zhao HB; Zhang XR
Neuroscience; 2010 Sep; 169(3):1046-62. PubMed ID: 20678995
[TBL] [Abstract][Full Text] [Related]
12. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin induces rat aortic endothelial cell proliferation and migration via activation of PI3K/Akt/mTOR/p70 S6 kinase signaling.
Nakao T; Shiota M; Tatemoto Y; Izumi Y; Iwao H
J Pharmacol Sci; 2007 Dec; 105(4):334-41. PubMed ID: 18057776
[TBL] [Abstract][Full Text] [Related]
14. The Akt/mTOR/p70S6K Pathway Is Involved in the Neuroprotective Effect of Erythropoietin on Hypoxic/Ischemic Brain Injury in a Neonatal Rat Model.
Lee HJ; Koh SH; Song KM; Seol IJ; Park HK
Neonatology; 2016; 110(2):93-100. PubMed ID: 27070481
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
17. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction pathways in FSH regulation of rat Sertoli cell proliferation.
Riera MF; Regueira M; Galardo MN; Pellizzari EH; Meroni SB; Cigorraga SB
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E914-23. PubMed ID: 22275758
[TBL] [Abstract][Full Text] [Related]
19. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H
Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032
[TBL] [Abstract][Full Text] [Related]
20. Insulin growth factor-1 enhances proliferation and inhibits apoptosis of neural progenitor cells by phosphorylation of Akt/mTOR/p70S6K molecules and triggering intrinsic apoptosis signaling pathway.
Zhang B; Hu L; Zhang J; Wu H; Li W; Gou L; Liu H
Cell Tissue Bank; 2022 Sep; 23(3):459-472. PubMed ID: 34494222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
